Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia

被引:92
作者
Banks, BA
Seri, I
Ischiropoulos, H
Merrill, J
Rychik, J
Ballard, RA
机构
[1] Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA
关键词
inhaled nitric oxide; bronchopulmonary dysplasia; chronic lung disease; prematurity; oxidant injury; pulmonary hypertension; clinical trial; nitrotyrosine;
D O I
10.1542/peds.103.3.610
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background. Severe bronchopulmonary dysplasia (BPD), which is associated with high mortality and morbidity, is thought to be the result of mechanical, inflammatory, and oxidant injury to the immature lung, and includes the development of pulmonary hypertension with vascular remodeling. Methods. A phase II pilot study was conducted to determine the effect of inhaled nitric oxide (iNO) on oxygenation in severe BPD. This was an open-labeled, noncontrolled trial to evaluate safety and determine appropriate dosing for a future randomized controlled trial. Infants were eligible for enrollment if they were greater than or equal to 4 weeks of age and ventilator dependent with a mean airway pressure of greater than or equal to 10 cm H2O and an FIO2 of greater than or equal to 0.45. Study infants received iNO (20 ppm) for 72 hours, and FIO2 was adjusted to maintain oxygen saturations of >92%. Infants who had a greater than or equal to 15% reduction in FIO2 after 72 hours received prolonged treatment with low-dose iNO, weaning by 20% every 3 days as tolerated. Findings. Sixteen preterm infants (23-29 weeks of gestation), age 1 to 7 months, were enrolled. Eleven of 16 infants had a significant increase in Fao, after 1 hour of iNO (median change, 24 mm Hg; range, -15 to 59 mm Hg; P <.01), but there was no significant change in PaCO2. After 72 hours of iNO, 11 infants had greater than or equal to 15% reduction in FIO2, and 7 of the 11 had greater than or equal to 35% reduction (P <.01). Among the 11 infants who responded to iNO after 72 hours, 10 had a sustained improvement in oxygenation throughout their course of treatment (duration, 8-90 days), and ventilator support could also be decreased. No adverse effects from iNO (increased methemoglobin, bleeding, or increased plasma 3-nitrotyrosine) were observed. Four of the 11 infants (36%) who responded to iNO ultimately weaned off mechanical ventilation and 4 died, whereas all the infants who failed to respond to iNO either died or continue to require mechanical ventilation. Interpretation. We conclude that the use of low-dose iNO may improve oxygenation in some infants with severe BPD, allowing decreased FIO2 and ventilator support without evidence of adverse effects. Randomized clinical trials of low-dose iNO for BPD are warranted.
引用
收藏
页码:610 / 618
页数:9
相关论文
共 56 条
  • [1] ABMAN SH, 1985, PEDIATRICS, V75, P80
  • [2] ACUTE EFFECTS OF INHALED NITRIC-OXIDE IN CHILDREN WITH SEVERE HYPOXEMIC RESPIRATORY-FAILURE
    ABMAN, SH
    GRIEBEL, JL
    PARKER, DK
    SCHMIDT, JM
    SWANTON, D
    KINSELLA, JP
    [J]. JOURNAL OF PEDIATRICS, 1994, 124 (06) : 881 - 888
  • [3] Antenatal thyrotropin-releasing hormone to prevent lung disease in preterm infants
    Ballard, RA
    Ballard, PL
    Cnaan, A
    Pinto-Martin, J
    Davis, DJ
    Padbury, JF
    Phibbs, RH
    Parer, JT
    Hart, MC
    Mannino, FL
    Sawai, SK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (08) : 493 - 498
  • [4] Plasma 3-nitrotyrosine is elevated in premature infants who develop bronchopulmonary dysplasia
    Banks, BA
    Ischiropoulos, H
    McClelland, M
    Ballard, PL
    Ballard, RA
    [J]. PEDIATRICS, 1998, 101 (05) : 870 - 874
  • [5] Banks Beverly A., 1997, Pediatric Research, V41, p246A
  • [6] PEROXYNITRITE INHIBITS SODIUM UPTAKE IN RAT COLONIC MEMBRANE-VESICLES
    BAUER, ML
    BECKMAN, JS
    BRIDGES, RJ
    FULLER, CM
    MATALON, S
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1104 (01) : 87 - 94
  • [7] BERMAN W, 1982, PEDIATRICS, V70, P708
  • [8] BLAND RD, 1997, PEDIATR RES, V41, P247
  • [9] ACUTE HEMODYNAMIC-EFFECTS OF NIFEDIPINE IN INFANTS WITH BRONCHOPULMONARY DYSPLASIA AND PULMONARY-HYPERTENSION
    BROWNLEE, JR
    BEEKMAN, RH
    ROSENTHAL, A
    [J]. PEDIATRIC RESEARCH, 1988, 24 (02) : 186 - 190
  • [10] CHANGES IN PULMONARY CIRCULATION IN SEVERE BRONCHOPULMONARY DYSPLASIA
    BUSH, A
    BUSST, CM
    KNIGHT, WB
    HISLOP, AA
    HAWORTH, SG
    SHINEBOURNE, EA
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1990, 65 (07) : 739 - 745